Hyppää sisältöön
    • Suomeksi
    • In English
  • Suomeksi
  • In English
  • Kirjaudu
Näytä aineisto 
  •   Etusivu
  • 3. UTUCris-artikkelit
  • Rinnakkaistallenteet
  • Näytä aineisto
  •   Etusivu
  • 3. UTUCris-artikkelit
  • Rinnakkaistallenteet
  • Näytä aineisto
JavaScript is disabled for your browser. Some features of this site may not work without it.

Technological readiness and implementation of genomic-driven precision medicine for complex diseases

Johnell K; Hall P; Sullivan PF; Smith JG; Friedman M; Malarstig A; Rosenquist R; Fall T; Gomez MF; Repsilber D; Jacobsson B; Oresic M; Klareskog L; Rönnblom L; Hägg S; Nordmark G; Bergen SE; Hagström H; Johansson Å; Jern C; Benson M; Orho-Melander M; Franks PW; Halfvarson J; Almqvist C; Ohlsson C; Czene K; Catrina A; Wadelius M; Sundstrom J; Melin B; Kockum I; Melen E

Technological readiness and implementation of genomic-driven precision medicine for complex diseases

Johnell K
Hall P
Sullivan PF
Smith JG
Friedman M
Malarstig A
Rosenquist R
Fall T
Gomez MF
Repsilber D
Jacobsson B
Oresic M
Klareskog L
Rönnblom L
Hägg S
Nordmark G
Bergen SE
Hagström H
Johansson Å
Jern C
Benson M
Orho-Melander M
Franks PW
Halfvarson J
Almqvist C
Ohlsson C
Czene K
Catrina A
Wadelius M
Sundstrom J
Melin B
Kockum I
Melen E
Katso/Avaa
Publisher´s pdf (823.1Kb)
Lataukset: 

WILEY
doi:10.1111/joim.13330
Näytä kaikki kuvailutiedot
Julkaisun pysyvä osoite on:
https://urn.fi/URN:NBN:fi-fe2021093048224
Tiivistelmä
The fields of human genetics and genomics have generated considerable knowledge about the mechanistic basis of many diseases. Genomic approaches to diagnosis, prognostication, prevention and treatment - genomic-driven precision medicine (GDPM) - may help optimize medical practice. Here, we provide a comprehensive review of GDPM of complex diseases across major medical specialties. We focus on technological readiness: how rapidly a test can be implemented into health care. Although these areas of medicine are diverse, key similarities exist across almost all areas. Many medical areas have, within their standards of care, at least one GDPM test for a genetic variant of strong effect that aids the identification/diagnosis of a more homogeneous subset within a larger disease group or identifies a subset with different therapeutic requirements. However, for almost all complex diseases, the majority of patients do not carry established single-gene mutations with large effects. Thus, research is underway that seeks to determine the polygenic basis of many complex diseases. Nevertheless, most complex diseases are caused by the interplay of genetic, behavioural and environmental risk factors, which will likely necessitate models for prediction and diagnosis that incorporate genetic and non-genetic data.
Kokoelmat
  • Rinnakkaistallenteet [19207]

Turun yliopiston kirjasto | Turun yliopisto
julkaisut@utu.fi | Tietosuoja | Saavutettavuusseloste
 

 

Tämä kokoelma

JulkaisuajatTekijätNimekkeetAsiasanatTiedekuntaLaitosOppiaineYhteisöt ja kokoelmat

Omat tiedot

Kirjaudu sisäänRekisteröidy

Turun yliopiston kirjasto | Turun yliopisto
julkaisut@utu.fi | Tietosuoja | Saavutettavuusseloste